Lv4
510 积分 2023-07-20 加入
Clinical toxicity of ADCs and ICI-ADC combinations: mechanisms, patterns and management
15小时前
待确认
Benmelstobart plus anlotinib versus pembrolizumab as first-line treatment for PD-L1-positive, advanced non-small-cell lung cancer (CAMPASS): a blinded, randomised, controlled, phase 3 trial
28天前
已完结
Feasibility and safety of nintedanib in combination with nivolumab in pretreated patients with advanced or metastatic adenocarcinoma of the lung – An AIO phase Ib/II trial
3个月前
已完结
Safety and Tolerability of Low-Dose Radiation and Stereotactic Body Radiotherapy + Sintilimab for Treatment-Naïve Stage IV PD-L1+ Non–Small Cell Lung Cancer Patients
3个月前
已完结
Recommendations on the management of kinase inhibitor-associated hyperlipidemia in patients with lung cancer
3个月前
已完结
皖公网安备34019202002308
